Matrix-Bio’s leadership team has extensive experience in biotechnology, healthcare and laboratory medicine. Team members have succeeded in developing and commercializing novel, game-changing medical technologies and raising angel/venture capital. We have retained a high-powered consulting team with oncology diagnostics expertise to accelerate testing and our go-to-market strategy.
Daniel Raftery, PhD, MBA
Founder and Chief Scientific Officer
Daniel Raftery is the chief scientific officer and founder of Matrix-Bio, Inc. A nationally recognized expert in the field of metabolomics, he invented the biomarker analysis methodology that forms the core of the company’s technology. He has more than 20 years of experience in nuclear magnetic resonance and mass spectrometry analysis, the gold standards for metabolite biomarker analysis.
Raftery is a Medical Education and Research Endowed Professor in the Department of Anesthesia and Pain Medicine and Director of the Northwest Metabolomics Research Center at the University of Washington in Seattle. He is also a member of one of the world’s leading cancer research centers, the Fred Hutchinson Cancer Research Center in Seattle. The National Institutes of Health and U.S. Department of Defense support Raftery’s work. Prior to joining the University of Washington, Raftery was a professor of Analytical and Physical Chemistry at Purdue University in West Lafayette, IN, where Matrix-Bio was founded in 2007.
A graduate of Harvard College, Raftery earned his PhD from the University of California, Berkeley. He earned his MBA from the University of Chicago. He completed a National Science Foundation postdoctoral fellowship at the University of Pennsylvania. He has received numerous national and international awards and is widely published.
Eric G. Beier, MD, MBA
Chief Executive Officer
A former emergency physician, medical consultant and seasoned entrepreneur, Eric Beier serves as the CEO of Matrix-Bio, Inc. and as a member of the Matrix-Bio Board of Directors representing the Main Street Venture Fund. An active angel investor, Matrix-Bio is his third start-up company. Beier also serves as an advisor to the Paladin Liberator Fund I, LP.. Previously, he was president of MedOptima, a physician revenue cycle management, practice management and consulting company he founded in 2005, and as president of Professional Medical Billing, an emergency medicine billing company. Beier served as the product line manager for cardiovascular diagnostics and in the Medical Affairs group at Boehringer Mannheim Corporation, now a part of Roche Diagnostics.
Beier graduated summa cum laude from Hanover College with a BA in Chemistry. He earned his medical degree from the Indiana University School of Medicine and an MBA from the University of Michigan.